Literature DB >> 3025552

Free amino acid levels in muscle and liver of a patient with glucagonoma syndrome.

E Roth, F Mühlbacher, J Karner, G Hamilton, J Funovics.   

Abstract

This study set out to measure the amino acid concentrations in the femoral artery, femoral vein, hepatic vein, muscular and hepatic tissue, and urine of a patient with the glucagonoma syndrome. The total plasma amino acid concentration was severely reduced on admission (737 mumol/L, 26% of normal), with only a slight increase during intravenous administration of 200 g of amino acids per day. The total intracellular amino acid levels in the muscle were 86%, and those of the liver were 47% of the normal range. Only 0.62% of the amino acids administered were found in the urine. Arteriovenous amino acid concentration differences across the muscle and splanchnic tissue indicated the release of amino acids (mainly glutamine, glycine, and alanine) from the muscle and the absorption of amino acids by the splanchnic bed. This study shows that the infusion of a high amount of amino acids cannot increase the subnormal plasma AA levels of patients with the glucagonoma syndrome. The low total plasma AA levels are paralleled by decreased intracellular free amino acid levels in the muscle and liver.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3025552     DOI: 10.1016/0026-0495(87)90055-2

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

1.  Evidence for a catabolic role of glucagon during an amino acid load.

Authors:  M R Charlton; D B Adey; K S Nair
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Increased amino acid clearance and urea synthesis in a patient with glucagonoma.

Authors:  T P Almdal; H Heindorff; L Bardram; H Vilstrup
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

3.  Rate of clinically significant postoperative pancreatic fistula in pancreatic neuroendocrine tumors.

Authors:  Suzanne M Inchauste; Brock J Lanier; Steven K Libutti; Giao Q Phan; Naris Nilubol; Seth M Steinberg; Electron Kebebew; Marybeth S Hughes
Journal:  World J Surg       Date:  2012-07       Impact factor: 3.352

4.  Aldehyde dehydrogenase 7A1 (ALDH7A1) attenuates reactive aldehyde and oxidative stress induced cytotoxicity.

Authors:  Chad Brocker; Miriam Cantore; Paola Failli; Vasilis Vasiliou
Journal:  Chem Biol Interact       Date:  2011-02-19       Impact factor: 5.192

Review 5.  Evolving diagnostic and treatment strategies for pancreatic neuroendocrine tumors.

Authors:  Matthew H Kulke; Johanna Bendell; Larry Kvols; Joel Picus; Rodney Pommier; James Yao
Journal:  J Hematol Oncol       Date:  2011-06-14       Impact factor: 17.388

6.  Effect of alanine supplementation on oxalate synthesis.

Authors:  Kyle D Wood; Brian L Freeman; Mary E Killian; Win Shun Lai; Dean Assimos; John Knight; Sonia Fargue
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-09-28       Impact factor: 5.187

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.